12:00 AM
 | 
Nov 01, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Plavix clopidogrel regulatory update

The U.K.'s NICE issued a final appraisal determination (FAD) recommending wider use of clopidogrel due to the availability of cheaper generic versions of the antiplatelet drug in the U.K. The agency recommends use of the adenosine diphosphate (ADP) receptor antagonist to prevent occlusive vascular events in patients who have had an ischemic stroke or have peripheral...

Read the full 266 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >